2015-01-13 01:00:02 – Pulmonary Drug Delivery Systems: Technologies and Global Markets – a new market research report on companiesandmarkets.com
The global market for pulmonary drug delivery technologies reached $32.4 billion in 2013 and is expected to grow to $43.9 billion in 2018, with a compound annual growth rate (CAGR) of 6.2%. The dry powder inhalers (DPIs) market reached $17.5 billion in 2013 and is expected to grow to $31.5 billion in 2018, with a CAGR of 12.5%. The nebulizers market reached $685 7million in 2013 and is expected to grow to $893.5million in 2018, with a CAGR of 5.4%.
Pulmonary drug delivery originated as a more relevant alternative for delivering drugs to the lungs. Respiratory conditions such as asthma, chronic obstructive pulmonary (COPD) and emphysema are therapeutic areas of the pulmonary space. Recent technological advancements have applied the application of
pulmonary devices to the treatment of nonrespiratory conditions also such as diabetes and migraines.
The recent trends and research in the formulating sector have grown tremendously and increased sales of dry powder inhalers (DPIs), and slowly replaced metered-dose inhalers (MDIs).
Pulmonary delivery of drugs for the treatment of respiratory diseases gives a faster, simpler and easier therapeutic effect compared to systemic treatments for these indications. In addition, it also reduces side effects associated with many drugs. Still, understanding the trends in this market, and currently available drug/device combinations and improving them and eliminating risks and problems, will help in faster, effective drug delivery to the lungs.
Technologies utilized to treat diseases like asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis using pulmonary route of drug administration are identified as pulmonary drug delivery systems. Technological advancements have brought a lot of change in the way the pulmonary drug delivery systems work. Various technically advanced inhalation systems available in the market include soft mist inhalers, breath actuated inhalers, and inhalers with integrated drug dose counters.
Major growth drivers for the pulmonary drug delivery systems market during the forecast period include increasing prevalence of respiratory diseases like asthma and COPD, numerous benefits associated with these systems and technological advancements both in drug formulations and delivery systems. According to the World Health Organisation (WHO), asthma affects nearly 300 million people, while COPD affects around 210 million people worldwide. The WHO also estimated a steep increase in the number of asthma and COPD patients worldwide in the coming future due to ever changing lifestyle and tobacco smoking habits. Benefits associated with these systems such as non-invasive nature of administration, low drug dosage requirement, site-specific targeted delivery and fast onset of action will boost market growth in future. This growth will also depend upon the technological advancements like introduction of breath-actuated MDIs (Autohaler by 3M Health Care and Combivent Respimat a soft mist inhaler from Boehringer Ingelheim), use of enantiomers of certain drugs (for example, Levosalbutamol an active enantiomer of salbutamol), and integration of dose counters.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.